Stanford University
Showing 15,181-15,200 of 36,233 Results
-
Aanchal Preet Kaur
Postdoctoral Scholar, Hematology-Oncology
BioDr. Aanchal Preet Kaur is a post-doctoral fellow in the Ramakrishna lab interested in understanding the role of myeloid cells in driving immunosuppression and resistance to CAR T cell therapies in pediatric patients with diffuse midline glioma. Her work involves developing organoid models to study the interaction of myeloid cells and CAR T cells and further employ these models to validate targets identified in patient single cell sequencing data using CRISPR technology.
Dr. Aanchal Preet Kaur received her PhD in Oncology at the University of Nottingham, United Kingdom where she focused on developing dendritic cell vaccines for melanoma. In her earlier post-doctoral work at Providence Cancer Institute with Dr. Michael Gough, she developed spheroid models to study the impact of radiation therapy on immune cell-cancer cell interactions. -
Amit Kaushal
Adjunct Professor, Bioengineering
BioAmit Kaushal, MD, PhD is Clinical Associate Professor of Medicine (Stanford-VA) and Adjunct Professor of Bioengineering at Stanford University. Dr. Kaushal's work spans clinical medicine, teaching, research, and industry.
He helped launch Stanford School of Engineering's undergraduate major in Biomedical Computation (bmc.stanford.edu) and has served as long-time director of the major. The major has graduated over 70 students since inception and was recently featured in Nature (https://go.nature.com/2P2UnRu).
His research interests are in utilizing health data in novel and ethical ways to improve the practice of medicine. He is a faculty executive member of Stanford's Partnership for AI-Assisted Care (aicare.stanford.edu). Recently, he has also been working with public health agencies to improve scale and speed of contact tracing for COVID-19.
He has previously held executive and advisory roles at startups working at the interface of technology and healthcare.
He continues to practice as an academic hospitalist.
Dr. Kaushal completed his BS (Biomedical Computation), MD, PhD (Biomedical Informatics), and residency training at Stanford. He is board-certified in Internal Medicine and Clinical Informatics. -
Dr Mohit Kaushal MD
Adjunct Professor, Biomedical Data Science
BioDr. Mohit Kaushal is an accomplished entrepreneur, investor, and physician with a distinguished career spanning clinical medicine, academia, public policy and industry. He has served as an investor and board member for numerous public and private transformative companies, including Oak Street Health (NYSE: OSH, acquired by CVS Health, NYSE: CVS), Humedica (acquired by Optum, NYSE: UNH), RxAnte (acquired by Millennium), Change Healthcare (acquired by Emdeon), Universal American (NYSE: UAM, acquired by WellCare, NYSE: WCG), goBalto (acquired by Oracle, NYSE: ORCL), CitiusTech (acquired by Baring), Wellframe (acquired by HealthEdge), and George Clinical (acquired by Hillhouse).
During the Obama administration, Dr. Kaushal served on the White House Health IT Task Force, contributing to the implementation of the Affordable Care Act’s technology initiatives and testifying before Congress on the role of technology and payment reform in Medicare. He also established and led the first dedicated healthcare team at the Federal Communications Commission, where his work included partnering with the FDA to streamline regulation of converged telecommunications, analytics, and medical devices, ultimately resulting in the FDA’s mobile medical applications guidance. His team also restructured the Rural Healthcare Fund into the Healthcare Connect Fund, aligning its resources with broader healthcare technology and payment reforms.
In academia, Dr. Kaushal is an Adjunct Professor in the Department of Biomedical Data Science at Stanford University, which integrates AI, biomedical informatics, biostatistics and computer science to advance precision health. His teaching emphasizes the application of data—ranging from molecular and tissue-level information to imaging, EHR, biosensors, and population health—to improve medical outcomes.
He remains active in public policy as a Scholar in Residence at the Duke-Margolis Center for Health Policy and was previously a Visiting Scholar at the Brookings Institution. His policy work includes previous appointments to the FDASIA Workgroup of the Health IT Policy Committee and the National Committee on Vital and Health Statistics, advising HHS on data access and use.
Dr. Kaushal is an emergency physician by training, holds an MBA from Stanford University, and earned his MD with distinction from Imperial College London.
